Matthew B. Murphy is General Counsel at Nautilus Biotechnology, Inc. (NAUT). They have made 3 open-market trades across 1 company since 2021, most recently 2025-09-04.
CIK 0001865778
3 open-market purchases totalling $79K since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NAUT | 74,140 | $153K |
Shares reported on the most recent Form 4, priced at the 2025-09-05 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.